XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Balance Sheets - USD ($)
Jun. 30, 2024
Jun. 30, 2023
Current Assets    
Cash $ 18,302 $ 39,495
Accounts receivable 3,749 0
Total Current Assets 22,051 39,495
Total Assets 22,051 39,495
Current Liabilities    
Accounts payable and accrued expenses 13,814 1,112
Advances from related parties 269,854 126,496
Common stock payable 9,559 9,559
Deferred revenue 37,098 23,841
Total Current Liabilities 330,325 161,008
Commitments and Contingencies (Note 7)
Stockholders’ Deficit    
Common stock, $0.001 par value, 300,000,000 shares authorized; 130,201,179 and 125,725,003 shares issued at June 30, 2024 and 2023 130,201 125,725
Additional paid-in-capital 13,443,466 13,123,419
Accumulated deficit (13,881,949) (13,370,665)
Total Stockholders’ Deficit (308,274) (121,513)
Total Liabilities and Stockholders' Deficit 22,051 39,495
Series A Preferred Stock [Member]    
Stockholders’ Deficit    
Preferred stock value 6 6
Series B Preferred Stock [Member]    
Stockholders’ Deficit    
Preferred stock value $ 2 $ 2